MedPath

Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient

Early Phase 1
Recruiting
Conditions
Blood Loss, Surgical
Interventions
Registration Number
NCT05427513
Lead Sponsor
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Brief Summary

investigator will see the efficacy of tranexamic acid in limb salvage surgery patients which will prevent blood loss and help in conservation of blood products.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Limb sarcoma of upper and lower limb
  • Limb salvage
Exclusion Criteria
  • liver insufficiency
  • renal insufficiency
  • allergic to drug
  • history of thromboembolic condition
  • pregnancy
  • metastatic disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placebonormal salinewill injection 10 ml of normal saline to ensure binding
tranexamic acid(TXA)Tranexamic acid injectionwill inject tranexamic acid according to body weight
Primary Outcome Measures
NameTimeMethod
blood loss72 hour post operatively

measure by hemoglobin direct method

no of blood transfused72 hour

measured by number of transfusion

Secondary Outcome Measures
NameTimeMethod
duration of hospital staytotal hospital stay post operatively for 02 month

Total days of hospital admission 2 months after surgery

volume of drain out putmeasure till drain out in 72 hour

to measure blood collected in drain bottle

thromboembolic eventsobserved for 6 week determine on out patient visits

look for limb swelling for deep vein thrombosis and chest symptoms for any embolic event confirmed by CT chest

Trial Locations

Locations (1)

Shaukat Khanum Memorial Cancer Hospital & Research Center

🇵🇰

Lahore, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath